pills-istock-499257708-stock-colors
stock_colors / iStockphoto.com
4 May 2018Americas

Allergan settles generic dispute with Aurobindo

Allergan and Ironwood Pharmaceuticals have reached a settlement with India-based Aurobindo Pharma, resolving litigation over a generic version of a constipation drug.

Ironwood announced the settlement with Aurobindo yesterday, May 3.

Allergan and Ironwood had sued the India-based company in response to Aurobindo’s Abbreviated New Drug Application (ANDA) which sought approval to market a generic version of Linzess (linaclotide).

Linzess is marketed by Allergan and Ironwood in the US to treat irritable bowel syndrome with constipation and chronic idiopathic constipation.

As part of the settlement, Aurobindo was granted a licence to market a generic version in the US from August 2030.

This settlement is the second patent infringement resolution reached over Linzess.

In July last year, Allergan sued Sun Pharma over an ANDA for a generic version of the drug, and a settlement was reached in January 2018.

Bill Meury, executive vice president and chief commercial officer of Allergan, said: “We are pleased to have resolved the patent litigation with Aurobindo. Allergan and Ironwood continue to invest in the Linzess franchise and to be confident in the product’s market leadership."

Did you enjoy reading this story?  Sign up to our free daily newsletters and get stories sent like this straight to your inbox.


More on this story

Americas
3 April 2018   Forest Laboratories, a subsidiary of Allergan, has taken on Mylan over a generic version of a constipation drug.
Americas
4 July 2017   Forest Laboratories and Allergan have filed a complaint against generic company Sun Pharma for patent infringement.

More on this story

Americas
3 April 2018   Forest Laboratories, a subsidiary of Allergan, has taken on Mylan over a generic version of a constipation drug.
Americas
4 July 2017   Forest Laboratories and Allergan have filed a complaint against generic company Sun Pharma for patent infringement.